Showing results (21-30 of 122) with videos related to
Sort By:
Pageof 13
British Medical Journal (Clinical Research Ed.)|June 14, 1986
Morphine intoxication in renal failure: the role of morphine-6-glucuronideR J Osborne, S P Joel, M L SlevinEuropean Journal of Biochemistry|March 1, 1978
Conversion of the active-site cysteine residue of papain into a dehydro-serine, a serine and a glycine residueP I Clark, G LoweCancer Chemotherapy and Pharmacology|January 1, 1984
The efficiency of protective gloves used in the handling of cytotoxic drugsM L Slevin, L M Ang, A Johnston, et al.Seminars in Oncology|December 1, 1992
The activity of 10-, 14-, and 21-day schedules of single-agent etoposide in previously untreated patients with extensive small cell lung cancerP I Clark, B CottierHuman Toxicology|November 1, 1985
Cardiac arrhythmias during cytotoxic chemotherapy: role of domperidoneR J Osborne, M L Slevin, R W Hunter, et al.British Journal of Cancer|October 1, 1990
Using mathematical models to estimate drug resistance and treatment efficacy via CT scan measurements of tumour volumeW M Gregory, R H Reznek, M Hallett, et al.Journal of Holistic Nursing : Official Journal of the American Holistic Nurses' Association|March 1, 1992
The "big three" cardiovascular risk factors among American blacks and HispanicsS J Gregory, P I ClarkEuropean Journal of Cancer & Clinical Oncology|May 1, 1985
Sequential methotrexate and 5-fluorouracil in the treatment of non-small cell carcinoma of the lungC D Wood, M L Slevin, B A Ponder, et al.British Journal of Cancer|January 1, 1988
Who should measure quality of life, the doctor or the patient?M L Slevin, H Plant, D Lynch, et al.Cancer Research|February 15, 1991
A mathematical model relating response durations to amount of subclinical resistant diseaseW M Gregory, M A Richards, M L Slevin, et al.Pageof 13